A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy-Reference-Cited by-同舟云学术

A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy

Published:2014-07-20 Issue:4 Volume:11 Page:840-856
ISSN:1933-7213
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Richter Franziska,Fleming Sheila M.,Watson Melanie,Lemesre Vincent,Pellegrino Lee,Ranes Brian,Zhu Chunni,Mortazavi Farzad,Mulligan Caitlin K.,Sioshansi Pedrom C.,Hean Sindalana,De La Rosa Krystal,Khanna Richie,Flanagan John,Lockhart David J.,Wustman Brandon A.,Clark Sean W.,Chesselet Marie-Françoise

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s13311-014-0294-x.pdf

Reference44 articles.

1. Hardy J. Genetic analysis of pathways to Parkinson disease. Neuron 2010;68:201-216.

2. Pankratz N, Nichols WC, Elsaesser VE, P et al. Alpha-synuclein and familial Parkinson's disease. Mov Disord 2009;24:1125–1131.

3. Trojanowski JQ, Lee VM. Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses. Ann N Y Acad Sci 2003;991:107–110.

4. Bultron G, Kacena K, Pearson D, et al. The risk of Parkinson's disease in type 1 Gaucher disease. J Inherit Metab Dis 2010;33:167–173.

5. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009;361:1651–1661.

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies;Cellular and Molecular Life Sciences;2024-09-03

2. LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy;European Journal of Pharmacology;2024-05

3. Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson’s disease;2024-03-27

4. The autophagy–lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson’s disease;Neural Regeneration Research;2024-01-31

5. Aldh1a1 and additional markers of dopamine cell heterogeneity in substantia nigra and ventral tegmental area identified as preserved in two transgenic α-synuclein mouse models of neurodegenerative disease;Exploration of Neuroprotective Therapy;2023-10-30